0001567619-22-020172.txt : 20221114 0001567619-22-020172.hdr.sgml : 20221114 20221114182044 ACCESSION NUMBER: 0001567619-22-020172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221109 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lind Global Macro Fund LP CENTRAL INDEX KEY: 0001773156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36612 FILM NUMBER: 221388416 BUSINESS ADDRESS: STREET 1: 444 MADISON AVE, FLOOR 41 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-395-3931 MAIL ADDRESS: STREET 1: 444 MADISON AVE, FLOOR 41 CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lind Global Fund II LP CENTRAL INDEX KEY: 0001871665 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36612 FILM NUMBER: 221388417 BUSINESS ADDRESS: STREET 1: 444 MADISON AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-701-7428 MAIL ADDRESS: STREET 1: 444 MADISON AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ReWalk Robotics Ltd. CENTRAL INDEX KEY: 0001607962 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 HATNUFA ST. STREET 2: FLOOR 6 CITY: YOKNEAM ILIT STATE: L3 ZIP: 2069203 BUSINESS PHONE: 97249590123 MAIL ADDRESS: STREET 1: 3 HATNUFA ST. STREET 2: FLOOR 6 CITY: YOKNEAM ILIT STATE: L3 ZIP: 2069203 FORMER COMPANY: FORMER CONFORMED NAME: Argo Medical Technologies Ltd. DATE OF NAME CHANGE: 20140513 4 1 doc1.xml FORM 4 X0306 4 2022-11-09 0 0001607962 ReWalk Robotics Ltd. RWLK 0001871665 Lind Global Fund II LP 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 0 0 1 0 0001773156 Lind Global Macro Fund LP 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022 0 0 1 0 Ordinary Shares, par value NIS 0.25 per share 2022-11-09 4 P 0 19727 0.90 A 4170025 I See Footnote Ordinary Shares, par value NIS 0.25 per share 2022-11-09 4 P 0 19727 0.90 A 4633916 I See Footnote Ordinary Shares, par value NIS 0.25 per share 2022-11-10 4 P 0 41737 0.88 A 4211762 I See Footnote Ordinary Shares, par value NIS 0.25 per share 2022-11-10 4 P 0 41738 0.88 A 4674916 I See Footnote Ordinary Shares, par value NIS 0.25 per share 2022-11-11 4 P 0 132313 0.92 A 4344075 I See Footnote Ordinary Shares, par value NIS 0.25 per share 2022-11-11 4 P 0 132312 0.92 A 4807228 I See Footnote Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein. Reflects securities held directly by Lind Global Macro Fund LP. Lind Global Partners LLC, the general partner of Lind Global Macro Fund LP, and Jeff Easton, the managing member of Lind Global Partners LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein. Weighted average sale price for Ordinary Shares sold. Actual sales price for shares sold ranged from $0.86 to $0.91. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price. Weighted average sale price for Ordinary Shares sold. Actual sales price for shares sold ranged from $0.92 to $0.93. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price. Lind Global Fund II LP, by: Lind Global Partners II LLC, its General Partner, by: /s/ Jeff Easton, its Managing Member 2022-11-14 Lind Global Macro Fund, LP by: Lind Global Partners LLC, its General Partner, by: /s/ Jeff Easton, its Managing Member 2022-11-14